Sorafenib Long Term Extension Program
NCT00625378
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
206
Enrollment
INDUSTRY
Sponsor class
Conditions
Neoplasms
Interventions
DRUG:
Sorafenib (Nexavar, BAY43-9006)
Sponsor
Bayer
Collaborators
[object Object]